{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:28:44Z","timestamp":1784942924455,"version":"3.55.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japanese Society of Peritoneal Dialysis"},{"DOI":"10.13039\/501100000024","name":"Canadian Institute for Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004702","name":"Baxter International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["2558-113"],"award-info":[{"award-number":["2558-113"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Rachadaphiseksompot Endorsement Fund","award":["GCURS_59_12_30_03"],"award-info":[{"award-number":["GCURS_59_12_30_03"]}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Thailand Research Foundation","award":["IR65780017"],"award-info":[{"award-number":["IR65780017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Peritoneal dialysis (PD)-related infections lead to significant morbidity. The International Society for Peritoneal Dialysis (ISPD) guidelines for the prevention and treatment of PD-related infections are based on variable evidence. We describe practice patterns across facilities participating in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PDOPPS, a prospective cohort study, enrolled nationally representative samples of PD patients in Australia\/New Zealand (ANZ), Canada, Thailand, Japan, the UK and the USA. Data on PD-related infection prevention and treatment practices across facilities were obtained from a survey of medical directors\u2019.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 170 centers, caring for &gt;11\u2009000 patients, were included. The proportion of facilities reporting antibiotic administration at the time of PD catheter insertion was lowest in the USA (63%) and highest in Canada and the UK (100%). Exit-site antimicrobial prophylaxis was variably used across countries, with Japan (4%) and Thailand (28%) having the lowest proportions. Exit-site mupirocin was the predominant exit-site prophylactic strategy in ANZ (56%), Canada (50%) and the UK (47%), while exit-site aminoglycosides were more common in the USA (72%). Empiric Gram-positive peritonitis treatment with vancomycin was most common in the UK (88%) and USA (83%) compared with 10\u201345% elsewhere. Empiric Gram-negative peritonitis treatment with aminoglycoside therapy was highest in ANZ (72%) and the UK (77%) compared with 10\u201345% elsewhere.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Variation in PD-related infection prevention and treatment strategies exist across countries with limited uptake of ISPD guideline recommendations. Further work will aim to understand the impact these differences have on the wide variation in infection risk between facilities and other clinically relevant PD outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ndt\/gfy204","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T19:31:41Z","timestamp":1529091101000},"page":"2118-2126","source":"Crossref","is-referenced-by-count":70,"title":["Regional variation in the treatment and prevention of peritoneal dialysis-related infections in the Peritoneal Dialysis Outcomes and Practice Patterns Study"],"prefix":"10.1093","volume":"34","author":[{"given":"Neil","family":"Boudville","sequence":"first","affiliation":[{"name":"Medical School, University of Western Australia, Perth, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A","family":"Bieber","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L","family":"Pisoni","sequence":"additional","affiliation":[{"name":"Arbor Research Collaborative for Health, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Piraino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Renal Electrolyte Division, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Bernardini","sequence":"additional","affiliation":[{"name":"Department of Medicine, Renal Electrolyte Division, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J","family":"Nessim","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Division of Nephrology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Rheumatology, Aichi Medical University School of Medicine, Nagakute, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Woodrow","sequence":"additional","affiliation":[{"name":"Department of Nephrology, St James's University Hospital, Leeds, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Renal Medicine, Auckland City Hospital, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talerngsak","family":"Kanjanabuch","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, and Kidney & Metabolic Research Unit, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheuk-Chun","family":"Szeto","sequence":"additional","affiliation":[{"name":"Carol & Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine & Therapeutics, Chinese University of Hong Kong, Shatin, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Perl","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, St. Michael\u2019s Hospital and the Keenan Research Center in the Li Ka Shing Knowledge Institute, St. Michael\u2019s Hospital, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"2019120308105215900_gfy204-B1"},{"key":"2019120308105215900_gfy204-B2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3747\/pdi.2010.00131","article-title":"Microbiology and outcomes of peritonitis in australian peritoneal dialysis patients","volume":"31","author":"Ghali","year":"2011","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B3","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/sj.ki.5001916","article-title":"Microbiology and outcomes of peritonitis in North America","volume":"70","author":"Mujais","year":"2006","journal-title":"Kidney Int"},{"key":"2019120308105215900_gfy204-B4","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1681\/ASN.2011121135","article-title":"Recent peritonitis associates with mortality among patients treated with peritoneal dialysis","volume":"23","author":"Boudville","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2019120308105215900_gfy204-B5","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1681\/ASN.V7102176","article-title":"Peritonitis influences mortality in peritoneal dialysis patients","volume":"7","author":"Fried","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"2019120308105215900_gfy204-B6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0272-6386(99)70428-2","article-title":"Hospitalization in peritoneal dialysis patients","volume":"33","author":"Fried","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2019120308105215900_gfy204-B7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1046\/j.1523-1755.2003.08801.x","article-title":"Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts","volume":"64","author":"Guo","year":"2003","journal-title":"Kidney Int"},{"key":"2019120308105215900_gfy204-B8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1440-1797.2010.01390.x","article-title":"Peritoneal dialysis practice in Australia and New Zealand: a call to action","volume":"16","author":"Jose","year":"2011","journal-title":"Nephrology"},{"key":"2019120308105215900_gfy204-B9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3747\/pdi.2016.00078","article-title":"ISPD peritonitis recommendations: 2016 update on prevention and treatment","volume":"36","author":"Li","year":"2016","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3747\/pdi.2015.00146","article-title":"Centre-specific factors associated with peritonitis risk\u2014a multi-center registry analysis","volume":"36","author":"Nadeau-Fredette","year":"2016","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3747\/pdi.2016.00120","article-title":"ISPD catheter-related infection recommendations: 2017 update","volume":"37","author":"Szeto","year":"2017","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2215\/CJN.12321216","article-title":"Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis","volume":"12","author":"Htay","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019120308105215900_gfy204-B13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3747\/pdi.2014.00288","article-title":"The Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS): unifying efforts to inform practice and improve global outcomes in peritoneal dialysis","volume":"36","author":"Perl","year":"2016","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B14","first-page":"CD004679","article-title":"Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients","volume":"4","author":"Campbell","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2019120308105215900_gfy204-B15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ndt\/12.1.157","article-title":"One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion","volume":"12","author":"Wikdahl","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"2019120308105215900_gfy204-B16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/ajkd.2000.19104","article-title":"Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters","volume":"36","author":"Gadallah","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2019120308105215900_gfy204-B17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00365599.1992.11690450","article-title":"Prophylactic antibiotics in the insertion of Tenckhoff catheters","volume":"26","author":"Lye","year":"1992","journal-title":"Scand J Urol Nephrol"},{"key":"2019120308105215900_gfy204-B18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3747\/pdi.2013.00240","article-title":"Knowledge, attitudes, and practices with regard to PD access: a report from the Peritoneal Dialysis Access Subcommittee of the Ontario Renal Network Committee on Independent Dialysis","volume":"34","author":"Shiff","year":"2014","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/ajkd.2002.33924","article-title":"An analysis of dialysis training in the United States and Canada","volume":"40","author":"Mehrotra","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2019120308105215900_gfy204-B20","first-page":"A1806","article-title":"Peritoneal dialysis training in U.S. nephrology training programs","volume":"12","author":"Yadlapalli","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2019120308105215900_gfy204-B21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2009.202","article-title":"Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients","volume":"76","author":"Miles","year":"2009","journal-title":"Kidney Int"},{"key":"2019120308105215900_gfy204-B22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3747\/pdi.2008.00189","article-title":"Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial","volume":"30","author":"Restrepo","year":"2010","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0272-6386(96)90466-7","article-title":"A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis","volume":"28","author":"Lo","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2019120308105215900_gfy204-B24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/nep.12731","article-title":"Peritoneal dialysis practice in Australia and New Zealand: a call to sustain the action","volume":"21","author":"Mudge","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"2019120308105215900_gfy204-B25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.ajkd.2014.02.025","article-title":"Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes","volume":"64","author":"Cho","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2019120308105215900_gfy204-B26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1177\/089686080702700517","article-title":"Risks and outcomes of peritonitis after flexible colonoscopy in CAPD patients","volume":"27","author":"Yip","year":"2007","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B27","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0272-6386(12)80276-9","article-title":"Posthysteroscopy fungal peritonitis in a patient on continuous ambulatory peritoneal dialysis. Am","volume":"21","author":"Li","year":"1993","journal-title":"J Kidney Dis"},{"key":"2019120308105215900_gfy204-B28","doi-asserted-by":"crossref","first-page":"e71532","DOI":"10.1371\/journal.pone.0071532","article-title":"Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"2019120308105215900_gfy204-B29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ndt\/gfp411","article-title":"Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis","volume":"25","author":"Xu","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2019120308105215900_gfy204-B30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1681\/ASN.2004090773","article-title":"Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients","volume":"16","author":"Bernardini","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2019120308105215900_gfy204-B31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/ajkd.2002.30553","article-title":"Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis","volume":"39","author":"Perez-Fontan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2019120308105215900_gfy204-B32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/08860220801964228","article-title":"Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience","volume":"30","author":"Cavdar","year":"2008","journal-title":"Ren Fail"},{"key":"2019120308105215900_gfy204-B33","first-page":"56","article-title":"Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis","volume":"25","author":"Mahaldar","year":"2009","journal-title":"Adv Perit Dial"},{"key":"2019120308105215900_gfy204-B34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/089686080802800514","article-title":"A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections","volume":"28","author":"Chu","year":"2008","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3747\/pdi.2011.00183","article-title":"The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis","volume":"32","author":"Pierce","year":"2012","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3747\/pdi.2011.00084","article-title":"Neighborhood location, rurality, geography, and outcomes of peritoneal dialysis patients in the United States","volume":"32","author":"Mehrotra","year":"2012","journal-title":"Perit Dial Int"},{"key":"2019120308105215900_gfy204-B37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ekir.2016.05.003","article-title":"The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis patients: the PROMPT study","volume":"1","author":"Muthucumarana","year":"2016","journal-title":"Kidney Int Rep"},{"key":"2019120308105215900_gfy204-B38","first-page":"CD005284","article-title":"Treatment for peritoneal dialysis-associated peritonitis","volume":"4","author":"Ballinger","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2019120308105215900_gfy204-B39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5009\/gnl.2014.8.1.1","article-title":"Clostridium difficile infection: a worldwide disease","volume":"8","author":"Burke","year":"2014","journal-title":"Gut Liver"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/12\/2118\/31193845\/gfy204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/12\/2118\/31193845\/gfy204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T20:45:21Z","timestamp":1661460321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/12\/2118\/5057652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":39,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,7,23]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy204","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2018,7,23]]}}}